Sustained Release Agent

Abstract Fluvoxamine maleate is efficient in treatment of depression and obsessive-compulsive disorder. However, it has several side effects which are...

Abstract Polyethoxylated (PEO)-based nonionic surfactants, such as D-α-Tocopheryl polyethylene glycol succinate (TPGS), offer significant advantages in drug delivery due to...

Introduction Gamma‑hydroxybutyrate (GHB) is an endogenous neurotransmitter also used pharmaceutically—usually as sodium oxybate—for treating narcolepsy and related disorders. It exerts...

Abstract Background: Modification of commercially available medicine, e.g. splitting or dissolving of tablets or pharmacy compounding, is current clinical practice...

BASF Pharma Solutions offers film-forming polymers and additive chemistries for your aesthetic, protective, and functional coating needs. BASF’s Kollicoat® portfolio...

Abstract Over the past decades, a variety of controlled-release technologies have been developed to maintain a constant drug release rate...

Abstract Inflammatory skin diseases are chronic conditions that significantly affect patients’ skin health and quality of life. Traditional treatments, including...

Abstract Imidafenacin tablets are the first-line drug for the treatment of overactive bladder (OAB). However, the tablets need to be...

Abstract Aim: The study aimed to develop a once-daily sustained-release gastroretentive combination formulation of bepotastine besilate and montelukast sodium using...

Abstract Linezolid (LNZ), oxazolidinone antibiotic, is widely used in clinical practice for treatment of bacterial keratitis. Despite its efficacy, the...